Multiple Myeloma Associated with HIV Infection in a Transgender Woman: Case Report and Review of an Integrated Management Approach
Main Article Content
Abstract
Multiple myeloma (MM) is a malignant hematologic neoplasm characterized by the clonal proliferation of plasma cells within the bone marrow, associated with the production of monoclonal immunoglobulins that lead to progressive bone destruction. This condition typically manifests with hypercalcemia, renal insufficiency, anemia, and lytic bone lesions, which constitute the CRAB criteria used for diagnosis. MM accounts for approximately 10% of hematopoietic neoplasms and about 1% of all cancers worldwide. The median age at diagnosis ranges from 65 to 70 years, and the disease is rare in individuals younger than 40 years. Established risk factors for MM include advanced age (predominantly affecting individuals over 65 years), male sex, African descent, obesity, the presence of monoclonal gammopathy of undetermined significance (MGUS), and certain precursor plasma cell disorders. MGUS is the most common precursor condition, with an estimated annual progression rate of approximately 1% to active multiple myeloma. Beyond classical risk factors, chronic states of immunosuppression, such as human immunodeficiency virus (HIV) infection, have been associated with humoral immune dysfunction and the development of plasma cell disorders. Epidemiological studies and case series suggest that patients living with HIV have an increased risk of developing monoclonal plasma cell disorders, including MGUS and MM, with some reports documenting a 2- to 5-fold higher risk compared with the general population. Clinical presentation in these patients also appears to occur at younger ages and with atypical features, posing an additional diagnostic challenge. This case highlights the importance of early diagnosis and comprehensive management in patients with HIV/AIDS, particularly those with poor adherence to antiretroviral therapy, who may be more susceptible to developing malignant hematologic conditions such as MM.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their articles and grant the journal the right of first publication under the Creative Commons Attribution (CC BY) license, which allows others to share and adapt the work with proper attribution.
References
Rajkumar SV, Kumar S, Lonial S, Mateos MV. Smoldering multiple myeloma current treatment algorithms. Blood Cancer J [Internet]. 2022;12(9):129. Disponible en: http://dx.doi.org/10.1038/s41408-022-00719-0
Rajkumar SV. Sequencing of myeloma therapy: Finding the right path among many standards. Hematol Oncol [Internet]. 2021;39 Suppl 1(S1):68–72. Disponible en: http://dx.doi.org/10.1002/hon.2848
Rajkumar SV, Kumar S. Multiple myeloma current treatment algorithms. Blood Cancer J [Internet]. 2020 [citado el 12 de enero de 2026];10(9):94. Disponible en: https://www.nature.com/articles/s41408-020-00359-2
Van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet [Internet]. 2021;397(10272):410–27. Disponible en: http://dx.doi.org/10.1016/S0140-6736(21)00135-5
Jessica Opie, Estelle Verburgh, Jenique Bailly, Elizabeth Mayne, Vernon Louw, Hematological Complications of Human Immunodeficiency Virus (HIV) Infection: An Update From an HIV-Endemic Setting, Open Forum Infectious Diseases, Volume 11, Issue 4, April 2024, ofae162, https://doi.org/10.1093/ofid/ofae162
Marshall M, Franz J, Rea B, Wheeler SE, Shurin MR. Annals of clinical pathology [Internet]. Jscimedcentral.com. 2024 [citado el 12 de enero de 2026]. Disponible en: https://www.jscimedcentral.com/public/assets/articles/pathology-11-1168.pdf
Moreau P, Kumar SK, San Miguel J, Davies F, Zamagni E, Bahlis N, et al. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. Lancet Oncol [Internet]. 2021;22(3):e105–18. Disponible en: http://dx.doi.org/10.1016/S1470-2045(20)30756-7
Human Physiology Students from University of Guelph. Calcium and phosphate regulation. En: Human Physiology. Disponible en: https://books.lib.uoguelph.ca/human-physiology/chapter/calcium-and-phosphate-regulation/
Abduh MS. An overview of multiple myeloma: A monoclonal plasma cell malignancy’s diagnosis, management, and treatment modalities. Saudi J Biol Sci [Internet]. 2024;31(2):103920. Disponible en: http://dx.doi.org/10.1016/j.sjbs.2023.103920
Zhou Q, Sun H, Fan S, Luo L, Ji J, Jiang Z, et al. Research trends between acquired immune deficiency syndrome and hematological malignancies: a bibliometric analysis. Discov Oncol [Internet]. 2025;16(1):1380. Disponible en: http://dx.doi.org/10.1007/s12672-025-03228-1
Carbone A, Vaccher E, Gloghini A. Hematologic cancers in individuals infected by HIV. Blood [Internet]. 2022;139(7):995–1012. Disponible en: http://dx.doi.org/10.1182/blood.2020005469
Andrés Hormaza-Jaramillo, Daniela Peñaloza Gonzalez, Sara Alejandra Benavides-Ibarra, Natalia Calvache Hernandez, Liliana Eugenia Muñoz Garcia, Alejandra Hidalgo Cardona, Jackeline Murrillo-Mera, Severe Complications Due to Biopolymers in a Patient With Autoimmune Disease: A Case Report and Review of the Literature, Aesthetic Surgery Journal Open Forum, Volume 7, 2025, ojaf099, https://doi.org/10.1093/asjof/ojaf099